Showing results (251-260 of 312) with videos related to

Sort By:
Pageof 32
Molecular and Cellular Biology|July 20, 2007
Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5Zhijun Duan, Richard E Person, Hu-Hui Lee, et al.
Gene Therapy|July 9, 2002
A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndromeN R Thummala, S S Ghosh, S W Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expressionY Ilan, G Droguett, N R Chowdhury, et al.
Biochemistry|December 24, 1991
Artificial mutants generated by the insertion of random oligonucleotides into the putative nucleoside binding site of the HSV-1 thymidine kinase geneD K Dube, J D Parker, D C French, et al.
Orthopedics|December 8, 2022
An Analysis of Formal Patient Complaints, Risk, and Malpractice Events Involving Orthopedic Trauma Surgeons During a 10-Year PeriodLouis C Grandizio, Daniela F Barreto Rocha, Daniel Hayes, et al.
Autoimmunity|October 9, 2012
Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) miceCaylib A Durand, Martin J Richer, Kathrin Brenker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) miceIan F Robey, Melissa Peterson, Marc S Horwitz, et al.
Science Advances|November 25, 2022
Gammaherpesvirus infection drives age-associated B cells toward pathogenicity in EAE and MSIsobel C Mouat, Jessica R Allanach, Naomi M Fettig, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphomaD R Mould, K Sweeney, S B Duffull, et al.
Hepatology (Baltimore, Md.)|May 15, 1998
Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenovirusesY Ilan, B Sauter, N R Chowdhury, et al.
Pageof 32